Psychology Department, Université de Montréal, Montreal, Canada.
Research Centre, Institut universitaire de gériatrie de Montréal, Montreal, Canada.
Aging Ment Health. 2020 Sep;24(9):1437-1443. doi: 10.1080/13607863.2019.1594167. Epub 2019 Apr 12.
Benzodiazepines (BZD) are often prescribed to address sleep difficulties but many BZD users report a poor quality of sleep. Although social support was found to be associated with quality of sleep in a recent meta-analysis, this relationship was never studied in older BZD users. This study thus aims to examine how social support is associated with quality of sleep in older BZD users. Seventy-two older adults (age 60-85) using BZD were recruited. Data was collected during the pre-test of the ''PASSE-60+; Support program for a successful withdrawal, NCT02281175'' study. Quality of sleep was measured using the Pittsburgh Sleep Quality Index (PSQI), while social support was evaluated with the Social Support Questionnaire (SSQ-6). When examining the various dimensions of self-reported sleep quality as a whole, we found no significant association with social support, while controlling for daily BZD dose, anxiety and depression. However, we found a significant association between self-reported diurnal dysfunctions (e.g., daytime sleepiness) and satisfaction with social support. Although the results of our study should be replicated with larger samples, they might indicate that social support is not a significant factor influencing sleep quality in older chronic BZD users. Our results could differ from those found in other populations because of the changes in sleep quality associated with long term BZD use. Longitudinal studies should analyse the relationship between diurnal dysfunctions and satisfaction with social support, to examine if social support could help older adults alleviate their diurnal dysfunctions and eventually facilitate BZD tapering.
苯二氮䓬类药物（BZD）常用于治疗睡眠障碍，但许多 BZD 用户报告睡眠质量较差。尽管最近的一项荟萃分析发现社会支持与睡眠质量有关，但从未在老年 BZD 用户中研究过这种关系。因此，本研究旨在探讨社会支持与老年 BZD 用户睡眠质量的关系。招募了 72 名使用 BZD 的老年成年人（60-85 岁）。数据是在“PASSE-60+；成功退出支持计划，NCT02281175”研究的预测试期间收集的。睡眠质量使用匹兹堡睡眠质量指数（PSQI）进行测量，而社会支持使用社会支持问卷（SSQ-6）进行评估。当我们整体检查自我报告的睡眠质量的各个维度时，发现社会支持与睡眠质量没有显著关联，而控制了每日 BZD 剂量、焦虑和抑郁。然而，我们发现自我报告的日间功能障碍（例如白天嗜睡）与对社会支持的满意度之间存在显著关联。尽管我们的研究结果应该用更大的样本进行复制，但它们可能表明社会支持不是影响老年慢性 BZD 用户睡眠质量的重要因素。我们的结果可能与其他人群的结果不同，因为长期使用 BZD 会导致睡眠质量发生变化。纵向研究应分析日间功能障碍与对社会支持的满意度之间的关系，以检查社会支持是否可以帮助老年人减轻日间功能障碍，并最终促进 BZD 逐渐减少。
